Article
Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study.
Ocular immunology and inflammation - 1 Dec 2024
Maccora Ilaria, Ebert Jared J, Schulert Grant S, Quinlan-Waters Megan, Duell Alexandra, Huggins Jennifer L, Sapp Cameron C, Nguyen Tiffany, Srivastava Sunil K, Sood Arjun B, Angeles-Han Sheila T
Abstract excerpt
BACKGROUND: Autosomal dominant neovascular inflammatory vitreoretinopathy (NIV), formerly called "ADNIV," is a rare autoinflammatory condition mainly of adulthood caused by mutations in calcium-activated calpain-5 protease (CAPN5). Our aim is to report the treatment and visual outcomes of children newly diagnosed with NIV after systemic treatment. METHODS: We reviewed charts of patients ≤18 years old with CAPN5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
